A GP panel discussion on immunisation as a preventative health strategy.
Learning objectives:
- Review the current disease burden of Herpes Zoster across the age groups, including high risk groups with underlying medical conditions.
- Review current AIH recommendations (NIP and private), and recommendations for individuals that have previously received Zostavax.
- Review Herpes Zoster immunisation rates for NIP eligible Australians including young individuals with risk factors and First Nations people.
- Discuss immunisation as a healthy aging strategy, and where Herpes Zoster fits into the picture.
- Highlight that a GP recommendation is one of the biggest factors that influences vaccination uptake.
- Discuss the pros and cons of embedding immunisation into routine preventative care, similar to heart health, weight management, diabetes care, and the Medicare-funded 75+ Health Assessment check.
- Discuss the latest real-world evidence of the benefits of Herpes Zoster prevention as part of healthy ageing.